Epignosis releases the TalentLMS 4.9 update

Epignosis LLC has released the latest update for TalentLMS, its award-winning learning management system. With TalentLMS 4.9, admins have more control over course scheduling, webinars, and reports.

TalentLMS 4.9 new and improved features:

  • Start date: With TalentLMS 4.9, users can now choose a start date for a course that unlocks course material at a set date in the future, regardless of when users are enrolled.
  • The Unit Matrix: With the introduction of the Unit matrix, users can now track a unit’s progress by a user, group, or branch at a glance.
  • Zoom Webinars: TalentLMS now integrates with Zoom Webinars, allowing users to use Zoom as their portal’s default web conferencing tool.
  • Video thumbnails: Users can now select a custom poster image for videos they upload to TalentLMS.

TalentLMS 4.9 also comes with improvements to SCORM reports.

Please see the official Release Notes for more details about new features, improvements, and bug fixes.

 

About TalentLMS

TalentLMS is the LMS built for training success. Designed to get a “yes” from everyone, it’s where great teams, and companies, go to grow. With an experience that’s fully customizable, easy to manage, and a joy to use, teams embrace training while feeling right at home. TalentLMS makes it easy to provide the right training for any team and every use, while giving expert guidance and support every step of the way. TalentLMS is on a mission to democratize training, serving over 70, 000 teams worldwide, 9000+ customers, and 11 million learners.

Learn more at https://www.talentlms.com

 

About Epignosis LLC

Epignosis is a leading software house in learning tech and trusted by over 70,000 teams worldwide. Its portfolio includes TalentLMS, a zero-overhead cloud LMS, eFront, an enterprise learning management platform, and TalentCards, a mobile app for training the deskless workforce. The company is paving the way for the democratization of training by developing premium eLearning tools that help teams reach their full potential.